ask="3.45"
ask_size="14000"
average_daily_volume="55598"
bid="N/A"
bid_size="N/A"
book_value="0.00"
change="+0.06"
change_from_200_day_moving_average="0.32"
change_from_50_day_moving_average="0.52"
change_from_52_week_high="-2.10"
change_From_52_week_low="1.18"
change_in_percent="+1.85%"
close="3.30"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.02"
ebitda="-17.23M"
eps_estimate_current_year="-1.11"
eps_estimate_next_quarter="-0.18"
eps_estimate_next_year="-0.83"
ex_dividend_date="N/A"
float_shares="10324000"
high="3.30"
high_52_weeks="5.40"
last_trade_date="3/17/2017"
last_trade_price="3.30"
last_trade_size="12131"
last_trade_time="4:00pm"
low="3.13"
low_52_weeks="2.12"
market_capitalization="70.62M"
moving_average_200_day="2.98"
moving_average_50_day="2.78"
name="Capricor Therapeutics
Inc."
notes="N/A"
one_year_target_price="12.00"
open="3.21"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+10.56%"
percent_change_from_50_day_moving_average="+18.56%"
percent_change_from_52_week_high="-38.89%"
percent_change_from_52_week_low="+55.66%"
previous_close="3.24"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1620.00"
price_per_sales="16.45"
revenue="4.22M"
shares_outstanding="21399000"
short_ratio="2.08"
stock_exchange="NCM"
symbol="CAPR"
volume="59278"
weeks_range_52="2.12 - 5.40"
